KOMPARASI BIAYA RIIL DENGAN TARIF INA-CBG�S DAN ANALISIS FAKTOR YANG MEMPENGARUHI BIAYA RIIL PADA PASIEN THALASEMIA RAWAT INAP JAMKESMAS DI RSUP Dr. SARDJITO YOGYAKARTA
| Main Authors: | , Aditya Maulana Perdana Putra, , dr. I Dewa Putu Pramantara S., SpPD., K-Ger |
|---|---|
| Format: | Thesis NonPeerReviewed |
| Terbitan: |
[Yogyakarta] : Universitas Gadjah Mada
, 2013
|
| Subjects: | |
| Online Access: |
https://repository.ugm.ac.id/119259/ http://etd.ugm.ac.id/index.php?mod=penelitian_detail&sub=PenelitianDetail&act=view&typ=html&buku_id=59254 |
Daftar Isi:
- In 2010, a package of INA-CBGs has been introduced. In 2011 organized health insurance in patients with thalassemia major who aim to help families of patients in treatment for thalassemia treatment cost is quite high. In the implementation of INA-CBGs occurs problems, one of which is related to the payment in which difference occurs between tariff of INA-CBGs with real cost. The aim of this research is to find out the extent of the difference between the real tariff and the tariff of INA-CBGs, difference factors and the description of the appropriateness of therapy towards the Jamkesmas inpatients with Thalassaemia at Sardjito Hospital Yogyakarta. This was an analytical-observational research with a design of retrospective research. The object of the research was the files of the inpatient claims and medical records of Jamkesmas patients with Thalassaemia in the period of April 2011 � March 2012 at Sardjito Hospital Yogyakarta. The data analysis is conducted with one sample test to compare between the rate of the real cost and the INA-CBG�s tariff. Meanwhile, the correlation test and the linear regression test is conducted to find out the cost factors. The result of the research showed a positive difference between the real cost and the tariff of INA-CBGs is IDR104.498.068 from 138 episodes of care. The average cost of healthcare for Thalassaemia based on the tariff of Sardjito Hospital at the severity level 1 that was IDR1.058.823 + 591.923. Three components with the most significant cost included the blood bag, drugs or medical stuffs and accommodation/hospitalization cost. The result of the correlation test showed that the blood bag, drugs and medical stuffs, hospitalization/accommodation, clinical pathology examination and visite have a strong influence towards the real cost. Meanwhile, from the value of variable coefficients (B) is known to influence the order of magnitude of the real costs is visite, hospitalization/accommodation, blood bag, drugs and medical stuffs, and clinical pathology examination. From the analysis of the suitability of an indication there are 5 drugs that are not consistent with the diagnosis of patients and one drug that is not appropriate patient.